BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28339284)

  • 1. DPC4 gene expression in primary pancreatic ductal adenocarcinoma: relationship with CT characteristics.
    Choi SH; Kim HJ; Kim KW; An S; Hong SM; Kim SC; Kim MH
    Br J Radiol; 2017 May; 90(1073):20160403. PubMed ID: 28339284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.
    Biankin AV; Morey AL; Lee CS; Kench JG; Biankin SA; Hook HC; Head DR; Hugh TB; Sutherland RL; Henshall SM
    J Clin Oncol; 2002 Dec; 20(23):4531-42. PubMed ID: 12454109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
    Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
    Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study.
    Shin SH; Kim HJ; Hwang DW; Lee JH; Song KB; Jun E; Shim IK; Hong SM; Kim HJ; Park KM; Lee YJ; Kim SC
    Oncotarget; 2017 Mar; 8(11):17945-17959. PubMed ID: 28160547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.
    Iacobuzio-Donahue CA; Klimstra DS; Adsay NV; Wilentz RE; Argani P; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Am J Pathol; 2000 Sep; 157(3):755-61. PubMed ID: 10980115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis.
    Elmi A; Murphy J; Hedgire S; McDermott S; Abtahi SM; Halpern E; Fernandez-Del Castillo C; Harisinghani M
    Abdom Radiol (NY); 2017 Aug; 42(8):2101-2107. PubMed ID: 28293721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced CT and diffusion-weighted MR imaging: performance as a prognostic factor in patients with pancreatic ductal adenocarcinoma.
    Fukukura Y; Takumi K; Higashi M; Shinchi H; Kamimura K; Yoneyama T; Tateyama A
    Eur J Radiol; 2014 Apr; 83(4):612-9. PubMed ID: 24418286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph nodes.
    La Torre M; Nigri G; Petrucciani N; Cavallini M; Aurello P; Cosenza G; Balducci G; Ziparo V; Ramacciato G
    Pancreatology; 2014; 14(4):289-94. PubMed ID: 25062879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologically different subgroups of invasive ductal carcinoma of the pancreas: Dpc4 status according to the ratio of intraductal carcinoma components.
    Takahashi H; Oda T; Hasebe T; Aoyagi Y; Kinoshita T; Konishi M; Nakagohri T; Inoue K; Takahashi S; Kawahira H; Monden M; Ochiai A
    Clin Cancer Res; 2004 Jun; 10(11):3772-9. PubMed ID: 15173084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
    Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
    Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
    Hua Z; Zhang YC; Hu XM; Jia ZG
    World J Gastroenterol; 2003 Dec; 9(12):2764-7. PubMed ID: 14669329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience.
    Marsoner K; Haybaeck J; Csengeri D; Waha JE; Schagerl J; Langeder R; Mischinger HJ; Kornprat P
    BMC Cancer; 2016 Nov; 16(1):844. PubMed ID: 27809876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling.
    McCarthy DM; Brat DJ; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Hum Pathol; 2001 Jun; 32(6):638-42. PubMed ID: 11431719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
    Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
    BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of immunohistochemical evaluation of protein expression in pancreatic ductal adenocarcinoma reveals prognostic significance for persistent Smad4 expression only.
    Ottenhof NA; Morsink FH; Ten Kate F; van Noorden CJ; Offerhaus GJ
    Cell Oncol (Dordr); 2012 Apr; 35(2):119-26. PubMed ID: 22351431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMAD4 genetic alterations predict a worse prognosis in patients with pancreatic ductal adenocarcinoma.
    Singh P; Srinivasan R; Wig JD
    Pancreas; 2012 May; 41(4):541-6. PubMed ID: 22504380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.
    Zheng J; Huang S; Huang Y; Song L; Yin Y; Kong W; Chen X; Ouyang X
    Tumour Biol; 2016 Jun; 37(6):7853-9. PubMed ID: 26695153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.